Next steps in trial registration

BMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7502.1222 (Published 26 May 2005) Cite this as: BMJ 2005;330:1222
  1. Kamran Abbasi, deputy editor (kabbasi@bmj.com),
  2. Fiona Godlee, Editor (fgodlee@bmj.com)
  1. BMJ, London WC1H 9JR

    Minimum criteria have been agreed, and intentions restated

    Last year medical journals responded to the growing clamour for greater transparency in the conduct of clinical trials by deciding to require registration of trials that are submitted for publication.1 Various groups have proposed criteria to clarify the implementation of this policy.2 3 These moves have received a mostly positive response from the public, regulators, and industry. Associations of pharmaceutical companies have signalled their support for registration of trials and recording of results although, regrettably, registration will only be voluntary.4 Individual pharmaceutical companies have announced their own initiatives, albeit under pressure from lawmakers and the needs of the market. 5

    Now the International Committee of Medical Journal Editors (ICMJE) has announced …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription